查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542557

全球细胞治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Cell Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 133 Pages | 商品交期: 最快1-2个工作天内

价格

全球细胞治疗市场需求预计将从2023年的53.2亿美元达到近347.2亿美元的市场规模，2024-2032年研究期间复合年增长率为23.18%。

细胞疗法是一种利用活细胞来治疗或预防疾病的医疗方法。这种方法旨在透过将健康细胞引入患者体内来替换或修復受损的细胞、组织或器官。该疗法涵盖多种技术，包括干细胞疗法（利用干细胞再生受损组织）和过继性细胞转移（其中修饰的免疫细胞靶向并摧毁癌细胞）。该疗法在许多领域都有应用，包括肿瘤学、血液学和再生医学。这种疗法透过利用人体的再生能力和增强免疫反应，为治疗以前无法治癒的疾病和病症带来了巨大的希望。正在进行的研究和临床试验继续推进细胞治疗的开发和应用。

市场动态

由于慢性和退化性疾病的盛行率不断增加，细胞治疗市场正在经历大幅增长。细胞疗法为癌症、心血管疾病和神经系统疾病等传统疗法可能不足的疾病提供了潜在的治疗方法。不断增长的患者群体和对创新治疗方案的需求推动了对先进细胞疗法的需求。技术进步代表了市场扩张的重大机会。细胞加工、基因编辑和细胞製造技术的创新正在提高细胞疗法的功效和安全性。 CRISPR-Cas9 基因编辑和先进的细胞培养方法等技术正在提高治疗的精确度和有效性，促进市场成长。个人化医疗的兴起也正在影响市场。这种疗法可以根据个别患者的情况进行客製化治疗，从而提高治疗效果并最大限度地减少不良反应。这种个人化方法的趋势与对客製化医疗保健解决方案的日益关注相一致，为市场成长创造了新的机会。

扩大细胞疗法的研发活动可推动创新和市场成长。对临床试验的投资、生物技术公司和研究机构之间的合作以及政府对该疗法研究的资助正在加速新疗法的开发并扩大可治疗疾病的范围。这些治疗产品的监管支持和批准进一步促进了市场成长。随着监管机构提供更清晰的审批和商业化途径，细胞疗法的开发和市场进入变得更加可行，吸引投资并增加先进治疗的可用性。然而，高昂的开发和製造成本、复杂的监管要求以及潜在的道德问题可能会限制市场成长。细胞疗法的长期功效和安全性挑战也可能影响广泛采用和市场接受度。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球细胞治疗市场的每个细分市场进行了包容性评估。细胞治疗产业的成长和趋势为这项研究提供了整体方法。

市场区隔

细胞治疗市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按治疗类型

  • 同种异体疗法（干细胞疗法（造血干细胞疗法、间质干细胞疗法）、非干细胞疗法（角质形成细胞和纤维母细胞疗法、其他）
  • 自体疗法（干细胞疗法（骨髓、血液和脐带源干细胞、脂肪源细胞等）
  • 非干细胞疗法（T细胞疗法（CAR T细胞疗法，基于T细胞受体（TCR）），其他

按治疗领域

  • 肿瘤学
  • 心血管疾病（CVD）
  • 肌肉骨骼疾病
  • 皮肤科
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲细胞治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。细胞治疗市场的主要参与者包括诺华公司、吉利德科学公司、百时美施贵宝公司、强生服务公司、JCR Pharmaceuticals Co. Ltd.、JW Therapeutics、Atara Biotherapeutics、Anterogen Co. Ltd.、Medipost、 S.生物医学。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：细胞治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按治疗类型分類的市场吸引力分析
    • 按治疗领域分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球细胞治疗市场分析：依治疗类型

  • 按治疗类型概述
  • 按治疗类型进行历史和预测数据分析
  • 同种异体疗法（干细胞疗法（造血干细胞疗法、间质干细胞疗法）、非干细胞疗法（角质形成细胞和纤维母细胞疗法、其他）
  • 自体疗法（干细胞疗法（骨髓、血液和脐带源干细胞、脂肪源细胞等）
  • 非干细胞疗法（T细胞疗法（CAR T细胞疗法，基于T细胞受体（TCR）），其他

第 6 章：全球细胞治疗市场分析：按治疗领域

  • 按治疗领域概述
  • 按治疗领域的历史和预测数据分析
  • 肿瘤学
  • 心血管疾病（CVD）
  • 肌肉骨骼疾病
  • 皮肤科
  • 其他的

第 7 章：全球细胞治疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：细胞治疗公司的竞争格局

  • 细胞治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Gilead Sciences Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bristol-Myers Squibb Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Johnson & Johnson Services Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • JCR Pharmaceuticals Co. Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • JW Therapeutics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Atara Biotherapeutics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Anterogen Co. Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Medipost
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • S.Biomedics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11210718

The global demand for Cell Therapy Market is presumed to reach the market size of nearly USD 34.72 Billion by 2032 from USD 5.32 Billion in 2023 with a CAGR of 23.18% under the study period 2024-2032.

Cell therapy is a medical treatment that uses living cells to treat or prevent disease. This approach aims to replace or repair damaged cells, tissues, or organs by introducing healthy cells into a patient's body. This therapy encompasses various techniques, including stem cell therapy, where stem cells are employed to regenerate damaged tissues, and adoptive cell transfer, where modified immune cells target and destroy cancer cells. The therapy has applications across numerous fields, including oncology, hematology, and regenerative medicine. This therapy holds significant promise for treating previously incurable diseases and conditions by harnessing the body's regenerative abilities and enhancing the immune response. Ongoing research & clinical trials continue to advance the development and application of cell-based treatments.

MARKET DYNAMICS

The cell therapy market is experiencing substantial growth attributed to the increasing prevalence of chronic & degenerative diseases. Cell therapy offers potential treatments for conditions such as cancer, cardiovascular diseases, and neurological disorders, where traditional therapies may be insufficient. The growing patient population and the need for innovative treatment options drive demand for advanced cell-based therapies. Technological advancements represent a significant opportunity for market expansion. Innovations in cell processing, gene editing, and cell manufacturing technologies are enhancing the efficacy and safety of cell therapies. Techniques such as CRISPR-Cas9 gene editing and advanced cell culture methods are improving the precision and effectiveness of treatments, fostering market growth. The rise in personalized medicine is also influencing the market. This therapy allows tailored treatments based on individual patient profiles, enhancing treatment outcomes and minimizing adverse effects. This trend towards personalized approaches aligns with the increasing focus on customized healthcare solutions, creating new opportunities for market growth.

Expanding research and development activities in cell therapy drives innovation and market growth. Investment in clinical trials, collaborations between biotech companies and research institutions, and government funding for this therapy research are accelerating the development of new therapies and expanding the range of treatable conditions. Regulatory support and approvals for these therapy products further contribute to market growth. As regulatory agencies provide clearer pathways for approval and commercialization, cell-based therapies' development and market entry become more feasible, attracting investment and increasing the availability of advanced treatments. However, high development and manufacturing costs, complex regulatory requirements, and potential ethical concerns may restrain market growth. Cell therapies' long-term efficacy and safety challenges could also impact widespread adoption and market acceptance.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cell Therapy. The growth and trends of Cell Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cell Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy Type

  • Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others)
  • Autologous Therapies (Stem Cell Therapies (BM, Blood & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others)
  • Non-Stem Cell Therapies (T-Cell Therapies (CAR T Cell Therapy, T Cell Receptor (TCR)-based), Others

By Therapeutic Area

  • Oncology
  • Cardiovascular Disease (CVD)
  • Musculoskeletal Disorders
  • Dermatology
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Therapy market include Novartis AG, Gilead Sciences Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, JCR Pharmaceuticals Co. Ltd., JW Therapeutics, Atara Biotherapeutics, Anterogen Co. Ltd., Medipost, S.Biomedics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CELL THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapy Type
    • 3.7.2 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CELL THERAPY MARKET ANALYSIS BY THERAPY TYPE

  • 5.1. Overview By Therapy Type
  • 5.2. Historical and Forecast Data Analysis By Therapy Type
  • 5.3. Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others) Historic and Forecast Sales By Regions
  • 5.4. Autologous Therapies (Stem Cell Therapies (BM, Blood & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others) Historic and Forecast Sales By Regions
  • 5.5. Non-Stem Cell Therapies (T-Cell Therapies (CAR T Cell Therapy, T Cell Receptor (TCR)-based), Others Historic and Forecast Sales By Regions

6. GLOBAL CELL THERAPY MARKET ANALYSIS BY THERAPEUTIC AREA

  • 6.1. Overview By Therapeutic Area
  • 6.2. Historical and Forecast Data Analysis By Therapeutic Area
  • 6.3. Oncology Historic and Forecast Sales By Regions
  • 6.4. Cardiovascular Disease (CVD) Historic and Forecast Sales By Regions
  • 6.5. Musculoskeletal Disorders Historic and Forecast Sales By Regions
  • 6.6. Dermatology Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CELL THERAPY COMPANIES

  • 8.1. Cell Therapy Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF CELL THERAPY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Novartis AG
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Gilead Sciences Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Bristol-Myers Squibb Company
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Johnson & Johnson Services Inc
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. JCR Pharmaceuticals Co. Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. JW Therapeutics
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Atara Biotherapeutics
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Anterogen Co. Ltd.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Medipost
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. S.Biomedics
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Therapy Type (USD MN)
  • Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others) Market Sales By Geography (USD MN)
  • Autologous Therapies (Stem Cell Therapies (BM, Blood & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others) Market Sales By Geography (USD MN)
  • Non-Stem Cell Therapies (T-Cell Therapies (CAR T Cell Therapy, T Cell Receptor (TCR)-based), Others Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiovascular Disease (CVD) Market Sales By Geography (USD MN)
  • Musculoskeletal Disorders Market Sales By Geography (USD MN)
  • Dermatology Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Cell Therapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cell Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Cell Therapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Therapy Type
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Therapy Type (USD MN)
  • Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies), Non-Stem Cell Therapies (Keratinocytes & Fibroblast-based Therapies, Others) Market Sales By Geography (USD MN)
  • Autologous Therapies (Stem Cell Therapies (BM, Blood & Umbilical Cord-derived Stem Cells, Adipose Derived Cells, Others) Market Sales By Geography (USD MN)
  • Non-Stem Cell Therapies (T-Cell Therapies (CAR T Cell Therapy, T Cell Receptor (TCR)-based), Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Cardiovascular Disease (CVD) Market Sales By Geography (USD MN)
  • Musculoskeletal Disorders Market Sales By Geography (USD MN)
  • Dermatology Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.